Sahota O, Mundey M K, San P, Godber I M, Hosking D J
Department of Health Care of the Elderly, Queens Medical Centre, University Hospital, B Floor South Block, Nottingham, NG7 2UH, UK.
Osteoporos Int. 2006;17(7):1013-21. doi: 10.1007/s00198-006-0084-3. Epub 2006 Apr 5.
Vitamin D insufficiency is common, however within individuals, not all manifest the biochemical effects of PTH excess. This further extends to patients with established osteoporosis. The mechanism underlying the blunted PTH response is unclear but may be related to magnesium (Mg) deficiency. The aims of this study were to compare in patients with established osteoporosis and differing degrees of vitamin D and PTH status : (1) the presence of Mg deficiency using the standard Mg loading test (2) evaluate the effects of Mg loading on the calcium-PTH endocrine axis (3) determine the effects of oral, short term Mg supplementation on the calcium-PTH endocrine axis and bone turnover.
30 patients (10 women in 3 groups) were evaluated prospectively measuring calcium, PTH, Mg retention (Mg loading test), dietary nutrient intake (calcium, vitamin D, Mg) and bone turnover markers (serum CTX & P1CP). Multivariate analysis controlling for potential confounding baseline variable was undertaken for the measured outcomes.
All subjects, within the low vitamin D and low PTH group following the magnesium loading test had evidence of Mg depletion [mean(SD) retention 70.3%(12.5)] and showed an increase in calcium 0.06(0.01) mmol/l [95% CI 0.03, 0.09, p=0.007], together with a rise in PTH 13.3 ng/l (4.5) [95% CI 3.2, 23.4, p=0.016] compared to baseline. Following oral supplementation bone turnover increased: CTX 0.16 (0.06) mcg/l [95%CI 0.01, 0.32 p=0.047]; P1CP 13.1 (5.7) mcg/l [95% CI 0.29, 26.6 p=0.049]. In subjects with a low vitamin D and raised PTH mean retention was 55.9%(14.8) and in the vitamin replete group 36.1%(14.4), with little change in both acute markers of calcium homeostasis and bone turnover markers following both the loading test and oral supplementation.
This study confirms that in patients with established osteoporosis, there is also a distinct group with a low vitamin D and a blunted PTH level and that Mg deficiency (as measured by the Mg loading test) is an important contributing factor.
维生素D缺乏很常见,然而在个体中,并非所有人都会表现出甲状旁腺激素(PTH)过量的生化效应。这一情况在已确诊骨质疏松症的患者中更为明显。PTH反应迟钝的潜在机制尚不清楚,但可能与镁(Mg)缺乏有关。本研究的目的是比较已确诊骨质疏松症且维生素D和PTH水平不同的患者:(1)使用标准镁负荷试验评估镁缺乏的情况;(2)评估镁负荷对钙 - PTH内分泌轴的影响;(3)确定口服短期补充镁对钙 - PTH内分泌轴和骨转换的影响。
前瞻性评估30例患者(3组,每组10名女性),测量钙、PTH、镁潴留(镁负荷试验)、膳食营养摄入(钙、维生素D、镁)和骨转换标志物(血清CTX和P1CP)。对测量结果进行多变量分析,以控制潜在的混杂基线变量。
在低维生素D和低PTH组中,所有受试者在镁负荷试验后均有镁缺乏的证据[平均(标准差)潴留率为70.3%(12.5)],与基线相比,钙水平升高了0.06(0.01)mmol/l [95%置信区间0.03,0.09,p = 0.007],同时PTH升高了13.3 ng/l(4.5)[95%置信区间3.2,23.4,p = 0.016]。口服补充镁后骨转换增加:CTX升高0.16(0.06)mcg/l [95%置信区间0.01,0.32,p = 0.047];P1CP升高13.1(5.7)mcg/l [95%置信区间0.29,26.6,p = 0.049]。在低维生素D和PTH升高的受试者中,平均潴留率为55.9%(14.8),在维生素充足组中为36.1%(14.4),在负荷试验和口服补充后,钙稳态和骨转换标志物的急性指标变化均不大。
本研究证实,在已确诊骨质疏松症的患者中,也有一组维生素D水平低且PTH水平迟钝的患者,并且镁缺乏(通过镁负荷试验测量)是一个重要的促成因素。